Codes / ICD10CM / T50.916D

T50.916D Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter (ICD-10 Code: T50.916D)

Summary

This condition describes a subsequent encounter for underdosing involving multiple unspecified drugs, medicaments, or biological substances. "Underdosing" refers to the administration of a subtherapeutic amount, while "multiple unspecified" indicates more than one substance is involved, and the exact agents are not identified or documented. The "subsequent encounter" modifier specifies this is a follow-up visit related to the underdosing event, distinct from the initial or acute phase of care.

Causes

Underdosing of multiple unspecified substances may result from therapeutic errors (e.g., incorrect dosing instructions), patient non-adherence, or inadequate monitoring of medication regimens. The cause is often unspecified when the exact substances or circumstances are not clearly documented, particularly in cases involving multiple agents where details are incomplete.

Risk Factors

  • Polypharmacy (use of multiple medications increasing complexity)
  • Cognitive impairment or memory issues affecting adherence
  • Lack of patient education on proper dosing
  • Inadequate follow-up for chronic conditions requiring drug therapy
  • Communication gaps between providers and patients

Symptoms

Symptoms depend on the substances involved and may include therapeutic failure (e.g., uncontrolled symptoms of the underlying condition), mild adverse effects from suboptimal dosing, or no obvious signs if the underdosing is subtle. The presentation can vary widely based on the drugs and the patient’s clinical status.

Diagnosis

Diagnosis is based on clinical evaluation, medication history, and documentation of underdosing. Providers assess whether the event is related to a specific substance or regimen, and whether it represents a subsequent encounter (e.g., follow-up for ongoing management). Laboratory tests or imaging may be used to evaluate the impact of underdosing, but the exact substances are often unspecified.

Treatment Options

Management focuses on correcting the underdosing, optimizing the medication regimen, and addressing any resulting clinical effects. This may involve adjusting doses, reinforcing patient education, or coordinating care with other providers. Supportive care is provided based on the patient’s symptoms and underlying condition.

Prognosis and Follow-Up

Prognosis depends on the severity of underdosing, the substances involved, and the patient’s overall health. Follow-up is typically recommended to monitor for therapeutic response, adherence, and potential complications. The "subsequent encounter" modifier indicates ongoing care related to the underdosing event.

Complications

Complications can include worsening of the underlying condition due to inadequate treatment, potential for adverse effects if doses are adjusted, or recurrence of underdosing if adherence issues persist. Long-term risks depend on the specific drugs and the patient’s clinical context.

Lifestyle & Prevention

Prevention strategies include simplifying medication regimens, using adherence tools (e.g., pill organizers), providing clear dosing instructions, and regular medication reviews. Patients should be educated on the importance of following prescribed doses and reporting any difficulties with adherence.

When to Seek Professional Help

Seek medical attention if underdosing leads to worsening symptoms, new adverse effects, or uncertainty about medication management. Follow-up is advised for ongoing issues related to dose adjustments or adherence.

Tips for Medical Coders

Document the encounter as a subsequent visit related to underdosing of multiple unspecified drugs. Ensure the "subsequent encounter" modifier (D) is applied correctly, and note that the substances are unspecified. Clinical documentation should clarify the nature of the underdosing and its impact on the patient’s care to support accurate coding.

Book a walkthrough

T50.916D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.